Takeda Pharmaceutical Company Limited
TREATMENT OF PAIN
Last updated:
Abstract:
The present invention relates to compounds and their uses. In particular, to compounds that inhibit endosomal protease-activated receptor-2 (PAR.sub.2) signaling and their use in the treatment of pain.
Status:
Application
Type:
Utility
Filling date:
19 May 2017
Issue date:
3 Oct 2019